タンパク質配列決定の世界市場2020-2074

◆英語タイトル:GLOBAL PROTEIN SEQUENCING MARKET FORECAST 2020-2028
◆商品コード:INK20MY063
◆発行会社(リサーチ会社):Inkwood Research
◆発行日:2020年3月
◆ページ数:159
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥262,500見積依頼/購入/質問フォーム
Multi LicenseUSD3,000 ⇒換算¥315,000見積依頼/購入/質問フォーム
Enterprisewide PriceUSD4,500 ⇒換算¥472,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Inkwood Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートではタンパク質配列決定の世界市場について調査・分析し、調査範囲・手法、エグゼクティブサマリー、市場動向、製品・サービス別(試薬・消耗品、器具、エドマン分解、質量分析、その他)分析、技術別(質量分析、エドマン分解)分析、用途別(学術研究機関、生物製剤、生物工学研究)分析、地域別分析、企業情報などの情報をお届けいたします。
・調査範囲・手法
・エグゼクティブサマリー
・市場動向
・主要分析
・タンパク質配列決定世界市場:製品・サービス別(試薬・消耗品、器具、エドマン分解、質量分析、その他)
・タンパク質配列決定世界市場:技術別(質量分析、エドマン分解)
・タンパク質配列決定世界市場:用途別(学術研究機関、生物製剤、生物工学研究)
・地域別分析
・企業情報
【レポートの概要】

KEY FINDINGS
The global protein sequencing market is anticipated to grow at a CAGR of 6.47% over the forecast period of 2020-2028. The factors boosting the growth of the global market are growing focus on target-based drug development, advances in computational proteomics, and developments in mass spectrometry and analytical techniques.

MARKET INSIGHTS
The process of protein sequencing provides information regarding the amino acids that make up a protein. An increasing number of innovations based on proteomics have propelled innovative drug development over the last few years. Moreover, several drugs have been developed with an emphasis on a single protein target. A target is usually a single gene, gene product, or molecular mechanism toward disease prognosis. Furthermore, protein sequencing has been adopted previously by big pharma and biotech companies. However, the latest technologies are becoming accessible and are developed even in academic research and small biotech. The factors restraining the growth of the market are a shortage of trained researchers and laboratory professionals, and excessive costs imposed on mass spectrometry equipment. Samples to be processed for protein production are often precious and limited, and thus require detailed proteome coverage. The purchase and the required support for the instruments are costly. The need for skilled professionals and the lack of automated processes also hinder the growth of the market. The market is consolidated due to the presence of a limited number of leading players.

REGIONAL INSIGHTS
The global protein sequencing market is geographically studied on the basis of markets present across the region of North America, Europe, Asia Pacific, and the Rest of the World. As of 2019, the region of North America captured the largest market share in terms of revenue and continues the trend by the end of the forecast period. This is attributed to technological advancements in sequencing platforms, and increasing applications of protein sequencing in this region.

COMPETITIVE INSIGHTS
Shimadzu Corporation, Proteome Factory Agilent Technologies Inc, SGS SA, Water Corporation, Bruker Corp etc. are some of the major players establishing their presence in the global market.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

【レポートの目次】

1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. MARKET DEFINITION
3.2. KEY DRIVERS
3.2.1. GROWING FOCUS ON TARGET-BASED DRUG DEVELOPMENT
3.2.2. DEVELOPMENTS IN MASS SPECTROMETRY AND ANALYTICAL TECHNIQUES
3.2.3. ADVANCES IN COMPUTATIONAL PROTEOMICS
3.3. KEY RESTRAINTS
3.3.1. SHORTAGE OF TRAINED RESEARCHERS AND LABORATORY PROFESSIONALS
3.3.2. EXORBITANT COST LEVIED BY INFRASTRUCTURE
4. KEY ANALYTICS
4.1. KEY INVESTMENT INSIGHTS
4.2. PORTER’S FIVE FORCE ANALYSIS
4.2.1. BUYER POWER
4.2.2. SUPPLIER POWER
4.2.3. SUBSTITUTION
4.2.4. NEW ENTRANTS
4.2.5. INDUSTRY RIVALRY
4.3. OPPORTUNITY MATRIX
4.4. VENDOR LANDSCAPE
5. MARKET BY PRODUCT AND SERVICE
5.1. REAGENTS AND CONSUMABLES
5.2. INSTRUMENTS
5.2.1. EDMAN DEGRADATION
5.2.2. MASS SPECTROMETRY
5.3. ANALYSIS PRODUCT
5.4. PROTEIN SEQUENCING SERVICES
6. MARKET BY TECHNOLOGY
6.1. MASS SPECTROMETRY
6.2. EDMAN DEGRADATION
7. MARKET BY APPLICATION
7.1. ACADEMIA
7.2. BIOPHARMACEUTICALS
7.3. BIOTECHNOLOGY RESEARCH
8. GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1. UNITED STATES
8.1.2. CANADA
8.2. EUROPE
8.2.1. UNITED KINGDOM
8.2.2. GERMANY
8.2.3. FRANCE
8.2.4. ITALY
8.2.5. RUSSIA
8.2.6. BELGIUM
8.2.7. POLAND
8.2.8. REST OF EUROPE
8.3. ASIA PACIFIC
8.3.1. CHINA
8.3.2. JAPAN
8.3.3. INDIA
8.3.4. SOUTH KOREA
8.3.5. INDONESIA
8.3.6. THAILAND
8.3.7. VIETNAM
8.3.8. AUSTRALIA & NEW ZEALAND
8.3.9. REST OF ASIA PACIFIC
8.4. REST OF WORLD
8.4.1. LATIN AMERICA
8.4.2. MIDDLE EAST & AFRICA
9. COMPANY PROFILES
9.1. SHIMADZU CORPORATION
9.2. AGILENT TECHNOLOGIES INC
9.3. THERMOFISHER SCIENTIFIC INC
9.4. PROTEOME FACTORY
9.5. WATER CORPORATION
9.6. BIOINFORMATICS SOLUTION
9.7. CHARLES RIVER LABORATORIES INC
9.8. SELVITA
9.9. RAPID NOVOR
9.10. SGS SA
9.11. BRUKER CORPORATION
9.12. TAKARA BIO



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[タンパク質配列決定の世界市場2020-2074]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆